News

Michelle Sahr is a financial advisor in Carmel, IN. They have been in practice for 10 years, the last 9 months at Capital Group / Capital Client Group, Inc.. Learn More About This Advisor.
These tariff management features will be demoed in FADEL's upcoming webinar, Tariffs, Royalties & Complexity: How to Future-Proof Licensing Deals.The online event will be held Wednesday, June 25 ...
Mr Smith has been the “driving force” of the society, the BNT said, providing 26 years of service by advising on and installing boxes and monitoring bluebird box trails across the island.
The financial gift follows the BNT’s Pig Roast 2025 fundraiser, which raised $100,000 for infrastructure projects at BPNP, including the development of a welcome centre.
#IN recognition of World Oceans Day, LOM Financial (Bahamas) Limited has donated $6,000 to the Bahamas National Trust (BNT) to support mangrove restoration at Bonefish Pond National Park (BPNP), a ...
FADEL®, innovator of rights and royalty management software, today announced capabilities in its flagship products, enabling companies to respond swiftly and strategically to evolving global tariff ...
These 2025 high school graduates can look back with pride and forward with confidence, as we salute them in our annual tribute to academic excellence.
BioNTech SE's $11.1bn BMS deal for BNT-327 highlights promise in PD-L1/VEGF oncology, but clinical validation is still needed. Despite strong COVID vaccine cash flow, ...
A large apartment fire broke out in Dubai in the Dubai Marina on the evening of June 13. All 3,820 residents of the 67-story building were safely evacuated, though many will now be living in ...
The MAGA movement is divided over how President Trump should react to escalating conflict between Israel — a U.S. ally — and Iran, including a suggestion that the U.S. could strike Iran.
Leila Fadel is a host of Morning Edition, as well as NPR's morning news podcast Up First. As a national correspondent, Fadel consistently reported on the fault lines of this divided nation. She ...
Biontech SE and Bristol Myers Squibb Co. are teaming up to develop Biontech’s bispecific antibody targeting PD-L1 and VEGF-A, BNT-327, in a deal possibly worth over $11 billion. The companies will ...